Elekta AB (OTCMKTS:EKTAY) Stock Short Interest Report for October

Elekta AB (OTCMKTS:EKTAY) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totaling 191 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 2,905 shares, the days-to-cover ratio is currently 0.1 days.

Elekta Stock Performance

Shares of OTCMKTS:EKTAY traded up $0.01 on Friday, reaching $5.92. 386 shares of the company’s stock were exchanged, compared to its average volume of 851. The firm has a market capitalization of $2.18 billion, a price-to-earnings ratio of -49.33 and a beta of 1.03. Elekta has a fifty-two week low of $4.35 and a fifty-two week high of $6.93. The business’s 50-day moving average is $5.41 and its two-hundred day moving average is $5.70. The company has a quick ratio of 0.62, a current ratio of 0.86 and a debt-to-equity ratio of 0.45.

Elekta (OTCMKTS:EKTAY) last posted its quarterly earnings results on Thursday, August 27th. The company reported $0.07 EPS for the quarter. Elekta had a negative net margin of 2.38% and a positive return on equity of 13.47%. The business had revenue of $372.30 million during the quarter. As a group, equities research analysts forecast that Elekta will post 0.43 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 28th. One investment analyst has rated the stock with a Hold rating. According to MarketBeat, the company presently has a consensus rating of “Hold”.

About Elekta

Elekta AB is a Sweden-based medical technology company that develops and supplies systems and software for radiation therapy, radiosurgery and related cancer-care applications. Its solutions are designed to help hospitals and clinics treat tumors while supporting more precise, personalized and less invasive care.

The company’s portfolio includes linear accelerators, stereotactic radiosurgery systems, magnetic resonance-guided radiation therapy technology and brachytherapy products. Elekta also provides oncology information systems and workflow software, including platforms used for treatment planning, patient management and clinical data coordination.

Founded in 1972 by neurosurgeon and inventor Lars Leksell, Elekta initially focused on radiosurgery and later expanded into broader radiation oncology.